[Webinar] 5 Years of ICER – Insights and Impact on Payers
Payers are increasingly reliant on ICER reports for their formulary decision making process. Join this webinar on Tuesday, September 15, [...]
Regulators Need to Plan Now For Allocating COVID-19 Vaccine
Not enough attention is being paid to how exactly a COVID-19 vaccine will be rolled out. What will happen after [...]
Non-submissions to NICE on the Rise Much to the Chagrin of the NHS
The National Institute for Health and Care Excellence’s (NICE) treatment appraisal is a voluntary process. If companies opt not to [...]
Emmy Award-winning Journalist, Epidemiologist, Author and Physician Seema Yasmin Slated to Give ISMPP West 2020 Keynote Address on October 1
Dr. Yasmin received her medical degree from the University of Cambridge and her journalism degree from the University of Toronto. [...]
With Dr. Robert Dubois at the Helm, the National Pharmaceutical Council (NPC) Solidifies Commitment to High-Quality Patient-Centered Research and Evidence-based Dialogue
Dr. Robert Dubois, the newly appointed interim president and CEO of NPC, outlined his vision for the organization during his [...]
New CMS Proposal Aims to Expand Coverage for Breakthrough Devices
On Monday, the Centers for Medicare and Medicaid Services announced a proposed rule that would provide four year coverage for [...]
How Can Bayesian Borrowing Enhance Use of Real World Data (RWD)?
As the use of real-world data becomes more common in trial design and regulatory submission, Bayesian borrowing techniques are of [...]
FDA’s Use of Real-World Data (RWD) in the Fight Against COVID-19 Leaves Much to Be Desired
Although the FDA has gone to great lengths to integrate RWD into the fight against COVID-19, the agency still has [...]
The Medical Affairs Role Receives a Makeover in Europe
The new MedTech regulatory environment in Europe is providing exciting new opportunities for the evolution of the Medical Affairs function, [...]
Challenge and opportunity abound Through Remote Patient Monitoring
Identifying a cohort and then recruiting and monitoring clinical trial patients is an expensive and time-consuming exercise. Remote Patient Monitoring [...]
How Can Payers Prepare for the New Normal When the Targets Keep Moving?
It is frequently said that the pandemic is ushering in a new normal, a normal that changes as our understanding [...]
Podcast with Dr. John Selby: ‘Right Now, It Is No Longer Optional to Suck at Patient Centricity’
Join Dr. Selby the [now-retired] executive director of Patient-Centered Outcomes Research Institute. (PCORI) for a discussion of the importance of [...]
Health Disparities Worsened by Structural Racism Inherent in Medicaid Program
Authors of a Health Affairs blog posit that Medicaid’s history and politics are evidence that the program is steeped in [...]
What is the Current State of Real-World Evidence (RWE) Across all Biopharmas?
The need for high-quality Real-World Evidence (RWE) is growing as drugmakers recognizing the enormous potential and value in RWE. Studies [...]
Blue Cross and Blue Shield North Carolina Saves Millions Through Value-based Care
Blue Cross and Blue Shield North Carolina (Blue Cross NC) implemented a value-based care program that achieved substantial cost savings [...]
Electronic Prior Authorizations are Gaining Steam
Prior authorizations are not very popular among providers due to their heavy administrative burden and the barriers they seem to [...]
ICER Assesses Cost-Effectiveness of Trained Service Dogs for Veterans with PTSD
The U.S. Department of Veterans Affairs (VA) commissioned the Institute for Clinical and Economic Review (ICER) to assess the cost-effectiveness [...]
Robert Dubois, MD, PhD, Steps in as Interim President and CEO of The National Pharmaceutical Council (NPC).
Today the National Pharmaceutical Council (NPC) announced the appointment of Robert Dubois, MD, PhD, as interim president and CEO, replacing [...]
When it Comes to COVID-19 Research, The US Still Has A lot to Learn
The US is thought to have the most talented scientists along with the best biomedical research infrastructure in the world. [...]
DIA DIRECT Webinar: Post-Pandemic Paradigm Shifts and New Dimensions of Value
Join Gregory Daniel, PhD, MPH, Head, US Healthcare Policy, Edwards Lifesciences; Rita Numerof, Co-Founder and President, Numerof & Associates; and [...]
ICER to Assess CAR-T Cell Therapies for Multiple Myeloma
The Institute for Clinical and Economic Review (ICER) announced its intention to evaluate the comparative clinical effectiveness and value of [...]
Draft Scoping Document on Lupus Nephritis Posted by ICER
In a draft scoping document, the Institute for Clinical and Economic Review (ICER) outlined plans to review the comparative clinical [...]
Amazon Launches Silent Healthcare Coup
In addition to its major market positions in logistics and cloud storage, Amazon is making quiet forays into healthcare. Although [...]
Gaps in Biosimilar Assessment Reports Pique Investigator Interest
According to a recent evaluation of health technology assessments (HTAs) for biosimilars, researchers found the majority of HTAs lack systematic [...]
Journal of Managed Care and Specialty Pharmacy (JMCP) Electronic Table of Contents Now Available for September 2020
Features in this issue include: Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System Editor’s [...]